All the news Showing 10 of 11 articles from: Treatment in acute infectionGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Updated CDC Guidance for Healthcare Personnel With Potential Exposure to HCV Infectious Disease Advisor / 24 August 2020 Short-course treatment for recent hepatitis C: some courses may be too short Keith Alcorn / 07 May 2020 An eight-week course of grazoprevir/elbasvir (Zepatier) achieved a high cure rate in people recently infected with hepatitis C, but another study found that a six-week course of sofosbuvir/velpatasvir (Epclusa) resulted in an inferior ... New US guidelines recommend screening of all adults for hepatitis C Keith Alcorn / 12 December 2019 All adults in the United States should be screened for hepatitis C by healthcare providers as part of routine medical care, updated guidelines from the American Association for the Study of Liver ... 8-week course of Zepatier cures acute HCV in people with HIV Liz Highleyman / 05 April 2018 An 8-week course of grazoprevir/elbasvir (Zepatier) produced sustained virological response in most HIV-positive gay men with recent hepatitis C virus (HCV) genotype 1 or 4 infection, according to a presentation at the ... Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV Liz Highleyman / 28 November 2017 An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to a sustained response in all people with HIV and genotype 1 or 4 hepatitis C virus (HCV) in the SWIFT-C study, according ... EASL issues new hepatitis C treatment recommendations for all genotypes Liz Highleyman / 26 September 2016 The European Association for the Study of the Liver (EASL) released its latest recommendations on treatment of hepatitis C at a special meeting last Thursday in Paris. The updated guidelines now include highly ... Six weeks of sofosbuvir/ledipasvir is enough to cure acute hepatitis C in HIV-negative people Liz Highleyman / 18 April 2016 A regimen of sofosbuvir/ledipasvir (Harvoni) taken for six weeks cured all patients with genotype 1 acute hepatitis C virus (HCV) infection, including those with high viral loads, according to findings from a ... Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low Liz Highleyman / 26 February 2016 An interferon- and ribavirin-free regimen of sofosbuvir/ledipasvir (Harvoni) taken for just 6 weeks was enough to cure hepatitis C in HIV-positive people with recent hepatitis C virus (HCV) infection if their HCV viral ... Adding telaprevir improves acute hepatitis C treatment for HIV-positive men Liz Highleyman / 12 March 2013 Adding telaprevir (Incivo or Incivek) to pegylated interferon and ribavirin shortens the duration of treatment and increases the likelihood of a cure for HIV-positive men with acute sexually transmitted hepatitis C virus ... HIV-positive patients who receive therapy for acute HCV can be cured with just 24 weeks of therapy Michael Carter / 06 June 2011 HIV-positive individuals with acute hepatitis C may be able to clear the infection with just 24 weeks of therapy, Dutch research published in the online edition of AIDS suggests. The retrospective study involved 50 ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive